0.61
1.18%
0.0071
アフターアワーズ:
.59
-0.02
-3.28%
前日終値:
$0.6029
開ける:
$0.61
24時間の取引高:
462.02K
Relative Volume:
0.76
時価総額:
$25.16M
収益:
$1.38M
当期純損益:
$-179.05M
株価収益率:
-0.0858
EPS:
-7.11
ネットキャッシュフロー:
$-155.03M
1週間 パフォーマンス:
+5.35%
1か月 パフォーマンス:
-0.81%
6か月 パフォーマンス:
-78.37%
1年 パフォーマンス:
-75.89%
Bioxcel Therapeutics Inc Stock (BTAI) Company Profile
名前
Bioxcel Therapeutics Inc
セクター
電話
203-643-8060
住所
555 LONG WHARF DRIVE, NEW HAVEN, CT
Bioxcel Therapeutics Inc Stock (BTAI) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-08-15 | ダウングレード | Mizuho | Buy → Neutral |
2023-07-17 | ダウングレード | Guggenheim | Buy → Neutral |
2023-03-10 | ダウングレード | Jefferies | Buy → Hold |
2022-12-01 | アップグレード | Goldman | Sell → Neutral |
2022-07-07 | 開始されました | Mizuho | Buy |
2022-04-06 | 繰り返されました | BofA Securities | Buy |
2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
2021-04-09 | 開始されました | Berenberg | Buy |
2021-02-01 | 開始されました | UBS | Buy |
2020-10-30 | 開始されました | Goldman | Buy |
2020-09-02 | 開始されました | Jefferies | Buy |
2020-08-17 | 繰り返されました | H.C. Wainwright | Buy |
2020-07-08 | 繰り返されました | H.C. Wainwright | Buy |
2020-06-04 | 開始されました | Guggenheim | Buy |
2020-04-01 | 開始されました | BofA/Merrill | Buy |
2020-02-26 | 繰り返されました | H.C. Wainwright | Buy |
2020-01-08 | 繰り返されました | H.C. Wainwright | Buy |
2019-11-12 | 開始されました | SunTrust | Buy |
すべてを表示
Bioxcel Therapeutics Inc (BTAI) 最新ニュース
The Potential Rise in the Price of BioXcel Therapeutics Inc (BTAI) following insiders activity - Knox Daily
BioXcel Therapeutics Inc: Weathering Stock Market Storms with 24.56M Market Cap - The InvestChronicle
Taking on analysts’ expectations and winning: BioXcel Therapeutics Inc (BTAI) - SETE News
BioXcel Therapeutics stock hits 52-week low at $0.53 By Investing.com - Investing.com Australia
BioXcel Therapeutics stock hits 52-week low at $0.53 - Investing.com
BTAI underperforms with a -2.28 decrease in share price - US Post News
Bank of New York Mellon Corp Buys 49,863 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
Is it a good time to sell Xcel Energy, Inc. [XEL] shares after an insider sold 2,041 shares? - Knox Daily
Blair William & Co. IL Has $2.01 Million Stock Position in Xcel Energy Inc. (NASDAQ:XEL) - Defense World
New Haven-based BioXcel faces delisting from Nasdaq stock exchange - Hartford Business Journal
Gaining Ground: BioXcel Therapeutics Inc (BTAI) Closes Lower at 0.58, Down -12.13 - The Dwinnex
Charting the Course: BioXcel Therapeutics Inc’s BTAI Stock Prospects - The InvestChronicle
Xcel Energy Inc. (NASDAQ:XEL) Shares Acquired by Sei Investments Co. - Defense World
Gabelli Funds LLC Sells 12,283 Shares of Xcel Energy Inc. (NASDAQ:XEL) - Defense World
BlackSky target adjusted to $15 from $2.50 at H.C. Wainwright - TipRanks
Summit Trail Advisors LLC Boosts Stock Position in Xcel Energy Inc. (NASDAQ:XEL) - Defense World
BlueLinx Holdings Inc. (NYSE:BXC) Shares Purchased by Massachusetts Financial Services Co. MA - Defense World
BioXcel Therapeutics faces Nasdaq delisting risk over share price - Investing.com
BioXcel Therapeutics faces Nasdaq delisting risk over share price By Investing.com - Investing.com Canada
BioXcel Therapeutics faces Nasdaq delisting risk over share price By Investing.com - Investing.com Australia
Meiji Yasuda Asset Management Co Ltd. Has $1.13 Million Holdings in Xcel Energy Inc. (NASDAQ:XEL) - Defense World
BioXcel Therapeutics faces Nasdaq delisting risk over share price By Investing.com - Investing.com UK
New Haven pharma firm BioXcel cuts jobs, shifts focus to agitation drug - CT Insider
New Haven pharma firm BioXcel cuts jobs, shifts focus to agitation drug - Greenwich Time
New Haven pharma firm BioXcel cuts jobs, shifts focus to agitation drug - Torrington Register Citizen
New Haven pharma firm BioXcel cuts jobs, shifts focus to agitation drug - The Advocate
BioXcel announces new priorities - The Pharma Letter
HC Wainwright Weighs in on BriaCell Therapeutics Corp.’s FY2029 Earnings (TSE:BCT) - Defense World
BioXcel Therapeutics (NASDAQ:BTAI) & Xenon Pharmaceuticals (NASDAQ:XENE) Head to Head Review - Defense World
Xcel Energy receives hold rating with $70 price target from Jefferies - Investing.com
BioXcel stock gains after new strategic focus (NASDAQ:BTAI) - Seeking Alpha
BioXcel Therapeutics refocuses on BXCL501 clinical trials - Investing.com
BioXcel Therapeutics announces workforce reduction to prioritize lead asset - Investing.com
New Haven-based BioXcel lays off 28% of workforce, including chief commercial officer - Hartford Business Journal
BioXcel Therapeutics refocuses on BXCL501 clinical trials By Investing.com - Investing.com Australia
BioXcel Therapeutics refocuses on BXCL501 clinical trials By Investing.com - Investing.com Canada
BioXcel announces clinical prioritization of late-stage BXCL501 programs - TipRanks
Bioxcel Therapeutics Announces Restructuring and Leadership Changes - TipRanks
BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for Agitation - GlobeNewswire
BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for Agitation - StockTitan
BioXcel Therapeutics CSO sells $244 in stock - Investing.com India
Bioxcel therapeutics executive sells over $148 in stock By Investing.com - Investing.com Australia
Bioxcel therapeutics executive sells over $148 in stock By Investing.com - Investing.com Canada
Bioxcel therapeutics executive sells over $148 in stock By Investing.com - Investing.com South Africa
BioXcel Therapeutics CEO sells over $1,300 in stock - Investing.com India
BioXcel Therapeutics CSO sells $244 in stock By Investing.com - Investing.com Australia
BioXcel Therapeutics executive sells shares worth $238 - Investing.com
BioXcel Therapeutics CEO sells over $1,300 in stock - Investing.com
Bioxcel therapeutics executive sells over $148 in stock - Investing.com
BioXcel Therapeutics CEO sells over $1,300 in stock By Investing.com - Investing.com UK
What is BioXcel Therapeutics Inc (BTAI) Stock Return on Shareholders’ Capital? - SETE News
Bioxcel Therapeutics Inc (BTAI) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):